State University of Montes Claros Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2007
NCT01568541
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Montes Claros State University | Montes Claros State University - Unimontes

Active Ingredients

Drugs in Phase 4 Trials (3)

amphotericin b (fungizone) (1 trial)

deoxycholic acid (kybella) (1 trial)

methylglucamine antimoniate (1 trial)

Drugs in Other Trials (1)

sodium fluoride (18F) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leishmaniasis (Phase 4)

Leishmaniasis, Visceral (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4